A prospective study to evaluate efficacy and safety of low dose fenfluramine in Belgian patients with Dravet syndrome
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Dec 2016
At a glance
- Drugs Fenfluramine (Primary)
- Indications Dravet syndrome
- Focus Adverse reactions; Therapeutic Use
- Sponsors Zogenix
- 06 Dec 2016 Results presented at the 70th Annual Meeting of the American Epilepsy Society
- 05 Dec 2016 Updated results published in the Zogenix Media Release.
- 05 Dec 2016 According to a Zogenix media release, data from this study were presented at the 70th Annual American Epilepsy Society (AES) meeting.